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The original version of this article unfortunately
contained a mistake in the presentation of Fig. 1 in both
the PDF and HTML versions of this manuscript [1]. In
the right panel of the corrected Fig. 1d, the images of
Mock cells, which were visualized with GFP and stained
with Abeta oligomer-specific antibody 11A1, were
replaced with those of APPWT cells, and instead the
images of APPWT cells were replaced with those of
Mock cells. These images had been incorrectly placed in
the original Fig. 1. The correct version of Fig. 1 is
presented below.
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Fig. 1 Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons
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Intracellular amyloid β oligomers impair
organelle transport and induce dendritic
spine loss in primary neurons
Tomohiro Umeda1,2, Elisa M. Ramser3, Minato Yamashita1, Koichi Nakajima4, Hiroshi Mori2,5,
Michael A. Silverman3* and Takami Tomiyama1,2*
Abstract
Introduction: Synaptic dysfunction and intracellular transport defects are early events in Alzheimer’s disease (AD).
Extracellular amyloid β (Aβ) oligomers cause spine alterations and impede the transport of proteins and organelles
such as brain-derived neurotrophic factor (BDNF) and mitochondria that are required for synaptic function. Meanwhile,
intraneuronal accumulation of Aβ precedes its extracellular deposition and is also associated with synaptic dysfunction
in AD. However, the links between intracellular Aβ, spine alteration, and mechanisms that support synaptic
maintenance such as organelle trafficking are poorly understood.
Results: We compared the effects of wild-type and Osaka (E693Δ)-mutant amyloid precursor proteins: the former
secretes Aβ into extracellular space and the latter accumulates Aβ oligomers within cells. First we investigated
the effects of intracellular Aβ oligomers on dendritic spines in primary neurons and their tau-dependency using
tau knockout neurons. We found that intracellular Aβ oligomers caused a reduction in mushroom, or mature
spines, independently of tau. We also found that intracellular Aβ oligomers significantly impaired the intracellular
transport of BDNF, mitochondria, and recycling endosomes: cargoes essential for synaptic maintenance. A
reduction in BDNF transport by intracellular Aβ oligomers was also observed in tau knockout neurons.
Conclusions: Our findings indicate that intracellular Aβ oligomers likely contribute to early synaptic pathology in AD
and argue against the consensus that Aβ-induced spine loss and transport defects require tau.
Introduction
Synaptic dysfunction is an early event in Alzheimer’s
disease (AD). Soluble oligomers of amyloid β (Aβ),
which are generated from the amyloid precursor pro-
tein (APP), are believed to be the primary synaptotox-
ins in AD. According to one central view of AD
pathogenesis, extracellular Aβ oligomers (eAβOs) bind
plasma membrane targets to elicit pre- and postsyn-
aptic intracellular effects (for reviews, [1, 2]). At the
postsynaptic membrane, eAβOs interact with glutam-
ate receptors and dysregulate calcium influx to impair
long-term potentiation (LTP) and enhance long-term
depression (LTD) [3–6]. eAβO binding also alters
spine morphology and decreases spine density [7, 8].
In axons, eAβOs impair transport of cargoes such as
mitochondria and vesicles containing brain-derived
neurotrophic factor (BDNF) [9–11], which are both
required for neuronal form and function.
Mitochondria are needed at presynaptic boutons to
maintain neurotransmission by producing ATP and
buffering synaptic calcium (Ca2+) [12–14]. Once se-
creted from axon terminals, BDNF increases spine
density and the proportion of mature spines by inter-
acting with postsynaptic TrkB receptors at the target
cell membrane [15, 16]. Thus, impaired transport of
mitochondria and BDNF might contribute to synaptic
dysfunction in AD [17, 18].
Although a role for eAβOs in causing AD-like tox-
icity is well established, several studies have revealed
that intraneuronal accumulation of Aβ is also toxic
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and precedes its extracellular deposition in patients
and model mice of AD [19–24]. In model mice that
overexpress mutant human APP, synaptic dysfunction
[22, 25], spine morphology alteration [26], and
axonal transport defects [27] were observed in asso-
ciation with intracellular Aβ oligomers (iAβOs).
These pathological changes, however, may have been
induced by overexpression of human APP or un-
detected extracellular Aβ. Cellular mechanisms that
underlie iAβO-induced synaptic dysfunction remain
uncharacterized. Furthermore, although it is widely
reported that tau is required for eAβO toxicity (for a
review, [28]), whether iAβO toxicity is tau-dependent
has not yet been investigated.
A valuable model for studying iAβOs is an APP
mutation identified in familial AD. The Osaka
(E693Δ) mutation in APP induces iAβO accumula-
tion without detection of Aβ fibrillization in vitro
and without detectable Aβ plaque formation in AD
patients or mouse models [29–31]. Intracellularly,
the Osaka mutation-induced iAβOs lead to endoplas-
mic reticulum stress and damage of mitochondria
and organelles within the endosomal/lysosomal sys-
tem [32].
Here, we determined and compared the effects of
wild-type APP (APPWT) and Osaka-mutant APP
(APPOSK) on dendritic spine morphology and intra-
cellular transport of organelles required for synaptic
maintenance and function. We found that iAβOs re-
duced the number of mature spines and impaired
transport of BDNF, mitochondria, and recycling
endosomes in hippocampal neurons expressing
APPOSK. Notably, spine reduction and impairment of
BDNF transport occurs independently of tau. These
results advance our understanding of early AD syn-
aptic pathology because iAβO accumulation precedes
extracellular amyloid deposition in patients and AD
model mice. Our findings may promote development
of effective therapeutic compounds for AD preven-
tion and treatment.
Materials and methods
Preparation of primary neurons
Mouse primary neurons were prepared from embryos of
wild-type (MAPT +/+) and tau knockout (MAPT −/−)
mice (Jackson Laboratory, Bar Harbor, ME) at embryonic
day 18 (E18). Hippocampal tissues were dissected in ice-
cold Hank’s balanced salt solution (HBSS; Sigma-Aldrich,
St. Louis, MO) and incubated in 1 ml of papain solution
(2 mg/ml in HBSS) at 37 °C for 30 min with gentle mixing.
After being washed with 5 ml of 50 % horse serum in
HBSS once, 5 ml of HBSS twice, and 4 ml of neuronal cul-
ture medium (Neurobasal, Electro medium supplemented
with B27, Electro and 500 μM L-glutamine; all from
GIBCO, Life Technologies, Carlsbad, CA) once, the
tissues were dissociated into cells by pipetting several
times with a Pasteur pipet in 2 ml of neuronal culture
medium. The cell suspensions were plated onto poly-L-
lysine-coated coverslips in 6-well culture plates at a
density of 170,000 cells/2 ml/well. For transport ana-
lyses, primary neurons from wild-type and tau knock-
out mice, and wild-type rats were prepared from
embryos at E16 and E18, respectively, as described [33].
Neurons were cultured on coverslips in Neurobasal
medium supplemented with B27 at a density of 250,000
cells/5 ml in 6 cm dishes. The astrocyte feeder layer for
the neuronal co-culture was generated using neural
progenitor cells as described previously [34].
Expression vectors
The pCI-APP construct was prepared using a pCI vector
(Promega, Madison, WI) as described previously [29]. A
pEGFP (enhanced green fluorescent protein)-N2 vector
was obtained from Clontech (Takara Bio Inc. Otsu,
Japan). The pIRES2-APP-EGFP vectors were made by
amplifying APPWT and APPOSK using a forward primer
containing an Nhe I restriction site (underlined) 5′-
AATTAATTAAGCTAGCGCCACCATGGGGGCTGC
CCGGTTTGGCACTGCT-3′ and a reverse primer
containing a Sac II restriction site 5′- TTAAT-
TAATTCCGCGGCTAGTTCTGCATCTGCTCAAA-
GAACTTGTAGGTTGG-3′ for subcloning into
pIRES2-EGFP (Takara Clontech Bio Inc. Otsu,
Japan). Plasmid composition was confirmed by se-
quencing. The pβ-actin-BDNF-mRFP (monomeric red
fluorescent protein) and pβ-actin-eBFP (enhanced
blue fluorescent protein) vectors were a kind gift
from Dr. G. Banker (Oregon Health and Sciences
University). The pcDNA3 Mt-eYFP (enhanced yellow
fluorescent protein) construct was designed to express
the COX IV mitochondrial-targeting sequence-EYFP
fusion proteins and kindly gifted from Dr. G. Rintoul
(Simon Fraser University). The JPA5-TfR -GFP vector
is described in Burack et al. [35].
Analyses of APP expression
Mouse primary neurons were cultured for 21 days in
vitro. The cells were cotransfected with pCI-APP
(APPWT, APPOSK, or empty) and pEGFP-N2 using a
Lipofectamine2000 reagent (Invitrogen, Life Tech-
nologies). Transfection was performed in the pres-
ence of 0.5 μM kynurenic acid (Sigma-Aldrich) to
lessen excitotoxic cell damage. Cells expressed the
transgenes for 2 days. For immunocytochemical ana-
lysis of APP expression, the cells were fixed with
4 % paraformaldehyde in PBS at room temperature
for 30 min and permeabilized by immersion in
0.05 % Tween-20 in PBS for a moment. After a brief
Umeda et al. Acta Neuropathologica Communications  (2015) 3:51 Page 2 of 15
wash, the cells were blocked with 20 % calf serum in
PBS at room temperature for 1 h. The cells were
then stained with human APP-specific antibody 6E10
(Covance, Berkeley, CA) or Aβ oligomer–specific
antibody 11A1 (IBL, Fujioka, Japan) at room
temperature for 1 h followed by Rhodamine-conjugated
anti-mouse IgG antibody (Jackson ImmunoResearch Labs,
West Grove, PA) at room temperature for 20 min. The
stained specimens were mounted with VECTASHIELD
mounting medium with DAPI (H-1500; Vector Laborator-
ies, Burlingame, CA) and viewed under a Leica TCS SP5
confocal laser microscope (Leica, Wetzlar, germany). For
Western blot analysis of APP expression, the cells were
lysed in 1 % Triton X-100/Tris-buffered saline (100 mM
Tris–HCl, pH 7.6, 150 mM NaCl) containing protease in-
hibitor cocktail P8340 (Sigma-Aldrich). The lysates were
separated by SDS-PAGE and transferred onto polyvinyli-
dene difluoride membranes. Human APP and actin were
stained with 6E10 and rabbit anti-actin antibody (Sigma-
Aldrich) followed by horseradish peroxidase–conjugated
secondary antibodies and chemiluminescent peroxidase
substrate (Millipore, Billerica, MA). Signals were visual-
ized and quantified using a LAS-3000 luminescent
image analyzer (Fujifilm, Tokyo, Japan).
Analyses of dendritic spines
Mouse primary neurons transfected with pCI-APP
and pEGFP-N2 were fixed with 4 % paraformalde-
hyde after a 2-day culture. The fixed cells were
mounted, and the images were taken using a Leica
TCS SP5 confocal laser microscope. Dendritic spines
were classified into four groups by the criteria as
follows: mushroom, the length ≤ 5 μm and the ratio
of neck width/head width ≥ 1.5; stubby, the length ≤
1 μm and the ratio of neck width/head width < 1.5;
thin, 1 < the length ≤ 5 μm and the ratio of neck
width/head width < 1.5; and fillopodia, the length ≥
1.5 μm without a head [36, 37]. Three to seven inde-
pendent cultures were made for each APPWT-,
APPOSK-, and mock transfection. One transfected
cell was chosen from each culture and analyzed for
spines with 3 to 12 dendrites per cell.
To study the effects of extracellular Aβ on spines,
we first determined the levels of Aβ secreted from
cells into culture media. Culture media of mouse pri-
mary neurons transfected with pCI-APP were har-
vested 2 days after transfection. Aβ concentrations in
the media were measured using a human/mouse
Aβ40 ELISA kit (Wako Pure Chemical Industries,
Osaka, Japan). Then, mouse primary neurons trans-
fected with pEGFP-N2 alone (without pCI-APP) were
cultured for 2 days in the presence of synthetic wild-
type Aβ42 or Osaka (E22Δ)-mutant Aβ42 (41 amino
acids) peptide (both from Peptide Institute, Mino,
Japan) at various concentrations. After cell fixation,
dendritic spines were analyzed as described above.
Analyses of axonal and dendritic transport
Mouse and rat primary neurons were cultured for
10–12 days in vitro. For analysis of BDNF transport,
mouse primary neurons were doubly transfected with
pIRES2-APP-EGFP and pβ-actin-BDNF-mRFP. For
analysis of mitochondria transport, rat primary neu-
rons were triply transfected with pCI-APP, pcDNA3
Mt-eYFP, and pmUBa-eBFP. To analyze recycling en-
dosome transport, we chose the transferrin receptor
(TfR) as a marker for recycling endosomes and used
pCI-APP, JPA5-TfR-GFP, and pmUBa-eBFP in trans-
fection of rat primary neurons. The soluble GFP and
BFP are distributed throughout the cell body and pro-
cesses enabling us to determine the orientation of the
cell body relative to the axon, thus, distinguishing an-
terograde and retrograde transport. All transfections
were done in the presence of 0.5 μM kynurenic acid
as described above. Two days after transfection,
BDNF/mitochondria/TfR transport was analyzed using
a standard wide-field fluorescence microscope
equipped with a cooled charge-coupled device camera
and controlled by MetaMorph (Molecular Devices,
Sunnyvale, CA) according to Kwinter et al. [38]. BDNF
imaging was recorded by the “stream acquisition mod-
ule”, and mitochondria and TfR imaging were recorded
by the “acquire timelapse module” in MetaMorph.
Briefly, cells were sealed in a heated imaging chamber,
and streaming recordings of BDNF were acquired from
triple transfectants for 25 s (250-msec exposures).
Frames were captured continuously for 300 s (400-msec
exposures) for mitochondria transport and 100 s (500-
msec exposures) for TfR transport. This captured dozens
of transport events per cell in 100-μm segments of the
axon and 45-μm segments of the dendrite. Axons and
dendrites were initially identified based on morphology
and confirmed retrospectively by immunostaining MAP2,
a dendrite-specific microtubule-associated protein, with
mouse anti-MAP2 antibody (Millipore). Vesicle flux was
obtained through tracing kymographs in MetaMorph.
Vesicle flux was defined as the total distance traveled
by vesicles standardized by the length and duration of
each movie (in micron-minutes): ∑i = 1
n di/(ℓ × t), where
d is the individual vesicle run lengths, ℓ is the length
of axon or dendrite observed, and t is the duration of
the observation [38].
Statistical analyses
All values obtained are expressed as the mean ±
SEM. Comparisons of means among multiple groups
were performed using Fisher’s PLSD test following
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ANOVA. Differences with a p value of <0.05 were
considered significant.
Results
Dendritic spines are altered in neurons accumulating iAβOs
Spines are generally classified into four types based on
the shape: stubby (type-I), mushroom (type-II), thin
(type-III), and filopodia-like protrusions. Mushroom
spines are stable and represent mature synapses, while
thin spines are transient and maintain structural plasti-
city [39]. Stubby spines are thought to be immature, and
filopodia-like protrusions lack synapses [39]. Due to the
reduction in synapses found in AD brains, we asked if
there is a change in the density and morphology of den-
dritic spines in APP expressing neurons. Mouse primary
neurons were transfected with two plasmid vectors to
simultaneously express APP and GFP, the latter was in-
troduced to visualize spines. By staining cells with hu-
man APP-specific 6E10 antibody, we confirmed that all
GFP-positive neurons expressed human APP (Fig. 1a).
Western blot analysis with the 6E10 antibody indicated
no significant difference in the levels of human APP ex-
pression between APPWT- and APPOSK-transfectants
(Fig. 1b and c). Importantly, only APPOSK-expressing
Fig. 1 APP expression and Aβ oligomer accumulation in APP-transfected neurons. Mouse primary neurons were transfected with two plasmid
vectors to simultaneously express APP and GFP. a Cells were stained with DAPI and human APP-specific 6E10 antibody (red). All GFP-positive
neurons expressed human APP. Scale bar, 200 μm. b Cell homogenates were subjected to Western blot with 6E10 and anti-actin antibodies.
c No significant difference in the levels of human APP expression between APPWT- and APPOSK-transfectants. AU, arbitrary unit. d Cells were
stained with 6E10 (red) or Aβ oligomer-specific 11A1 antibody (red). Only APPOSK-expressing neurons accumulated abundant iAβOs. Scale
bar, 30 μm
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neurons accumulated abundant iAβOs, which were visu-
alized by staining with the Aβ oligomer-specific 11A1
antibody (Fig. 1d). We classified individual spines on
dendrites of GFP-positive neurons into the four types,
and compared the numbers of total and each type spines
among APPOSK-expressing, APPWT-expressing, and
mock-transfected neurons (Fig. 2). Compared with
mock-transfectants, APPWT-expressing cells showed a
small increase in the number of total and mushroom-
type spines with no significant changes in other types. In
contrast, APPOSK-expressing cells exhibited a significant
reduction in the number of total and mushroom-type
spines, but no significant changes in other types. Taken
together, these results suggest that the accumulation of
iAβOs markedly decreases spine density, particularly the
mature mushroom-type spines.
Spine reduction is not a result of extracellular Aβ
Altered spine density and morphology may have been
induced by extracellular Aβ secreted from cells. To test
this possibility, we first measured the levels of Aβ in the
culture media using a human/mouse Aβ40 ELISA kit.
The culture media of mock-, APPWT-, and APPOSK-
transfectants contained about 89.5 ± 17.1, 183.5 ± 15.1,
and 63.8 ± 4.5 pM of Aβ40, respectively. This is consist-
ent with our previous finding that the Osaka mutation
reduced Aβ secretion [30].
Subsequently we added synthetic Aβ42 peptide into cul-
ture media of GFP-expressing neurons at various concen-
trations. Before adding the peptides, we examined Aβ
oligomer formation in the peptide solutions by Western
blot using the 6E10 antibody. Wild-type Aβ42 peptide
showed mainly monomers and with a faint signal for
Fig. 2 Spine alteration in APPOSK-expressing neurons. a Mouse primary neurons were doubly transfected with APP and GFP. Scale bar, 30 μm. Lower
panels, enlarged views of the dendrites surrounded with a square. b Individual spines on dendrites of GFP-positive neurons were classified into the
four types: mushroom, stubby, thin, and filopodia-like protrusions. Compared with mock-transfectants, APPWT-expressing cells showed a small increase
the number of total and mushroom-type spines with no significant changes in other types. In contrast, APPOSK-expressing cells exhibited a significant
reduction in the number of total and mushroom-type spines, but no significant changes in other types
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dimers, whereas the Osaka-mutant Aβ42 peptide exhib-
ited abundant monomers as well as dimers, trimers, tetra-
mers, and 12-mers (Fig. 3a). After 48 h exposure to Aβ
peptides, spine densities and types were measured in pri-
mary neurons. Unexpectedly, wild-type Aβ42 peptide in-
creased total and mushroom-type spines at physiological,
low concentrations (100 pM to 400 pM; Fig. 3b) [40, 41].
However, such a trophic effect was attenuated at concentra-
tions over 1 nM. At 25 nM, wild-type peptide significantly
decreased total and mushroom-type spines. In contrast, the
Osaka-mutant Aβ42 peptide did not affect spine morph-
ology at low concentrations (100 pM – 400 pM), yet signifi-
cantly decreased total and mushroom-type spines at higher
concentrations over 1 nM (Fig. 3c). These results are con-
sistent with our previous observation that wild-type, but
not Osaka-mutant, Aβ42 peptide showed a trophic effect
on synaptophysin levels in cultured mouse hippocampal
slices [42]. The present result with wild-type Aβ peptide
Fig. 3 Effects of extracellular Aβ on spines. Synthetic wild-type (WT) or Osaka-mutant (OSK) Aβ42 peptides were added into culture media
of GFP-expressing neurons at various concentrations. a Before adding the peptides, Aβ oligomer formation in the peptide solutions were
examined by Western blot with 6E10 antibody. Aβ WT peptide showed mainly monomers and faintly dimers, whereas Aβ OSK peptide
exhibited abundant monomers as well as dimers and trimers and faintly tetramers and 12-mers. b, c After a 2-day culture in the presence
of Aβ peptides, spine densities and types were measured. Aβ WT peptide (b) increased total and mushroom-type spines at physiological,
low concentrations from 100 pM to 400 pM. In contrast, Aβ OSK peptide (c) did not affect spine morphology at those concentrations.
However, both Aβ WT and Aβ OSK peptides significantly decreased total and mushroom-type spines at higher concentrations: at 25 nM
of Aβ WT peptide and over 1 nM of Aβ OSK peptide
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Fig. 4 Spine alteration in APPOSK-expressing tau knockout neurons. a Primary neurons were prepared from tau knockout mice and doubly
transfected with APP and GFP. Scale bar, 30 μm. Lower panels, enlarged views of the dendrites surrounded with a square. b Spine
density and morphology in GFP-positive neurons were analyzed. APPWT-expressing cells showed no differences in the number of total
and each type spine compared to mock-transfectants. In contrast, APPOSK-expressing cells exhibited a significant reduction in the number
of total and mushroom-type spines with no significant changes in other types. c, d Comparison of spine alteration between wild-type
(Fig. 2) and tau knockout neurons expressing APPOSK. c There were no differences in the density of mushroom-type and total spines
between wild-type and tau knockout neurons. d APPOSK expression reduced the spine density in both wild-type and tau knockout
neurons: No differences in the reduction of mushroom-type (p = 0.4835) and total spines (p = 0.9702) between these neurons
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implies that the increase in total and mushroom-type
spines observed in APPWT-expressing neurons (Fig. 2)
might be induced by extracellular Aβ secreted from the
cells. On the contrary, the result with the Osaka-mutant Aβ
peptide suggests that the spine alterations observed in
APPOSK-expressing neurons (Fig. 2) could be attributed to
iAβOs.
iAβO-induced spine alteration is independent of tau
Whether extracellular Aβ requires tau to mediate
changes in postsynaptic structure remain a topic of de-
bate. One model suggests that postsynaptic defects
occur upstream of significant changes in tau phosphoryl-
ation [43], yet recent studies indicate tau hyperpho-
sphorylation and mislocalization leads to postsynaptic
deficits [44–46]. However, it is unknown if tau is required
for iAβOs to exhibit toxic effect on spines. Primary
neurons were prepared from tau knockout mice and
doubly transfected with APP and GFP. We confirmed
again that all GFP-positive neurons expressed human APP
and that only APPOSK-expressing neurons accumulated
abundant iAβOs (data not shown). Similar to the experi-
ments in wild-type neurons we analyzed spine density and
morphology in GFP-positive neurons. APPWT-expressing
Fig. 5 Axonal and dendritic transport of BDNF is impaired in APPOSK-expressing neurons. Wild-type mouse primary neurons were doubly
transfected with APP-EGFP and BDNF-mRFP. Transport of BDNF in living neurons was recorded for 25 s, and those in 100-μm segments
of the axon (a) and 45-μm segments of the dendrite (c) were analyzed. Axons and dendrites were initially identified based on morphology and
confirmed retrospectively by immunostaining MAP2. b Compared with mock-transfectants, both APPWT- and APPOSK-expressing cells showed a decrease
of bidirectional transport of BDNF in axons, but the differences were significant only in APPOSK-expressing cells. d Similarly, a decrease of bidirectional
transport of BDNF in dendrites was observed in both APPWT- and APPOSK-expressing cells, but significant reduction was observed only for total event in
APPOSK-expressing cells
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cells showed no differences in the number of total spines
and morphologically distinct spines compared to mock-
transfectants (Fig. 4a, b). The trophic effect of APPWT
expression on total and mushroom-type spines was not
seen in tau knockout neurons. In contrast, APPOSK-ex-
pressing cells exhibited a significant reduction in the num-
ber of total and mushroom-type spines with no significant
changes in other types. Finally, we observed no significant
differences in spine alteration between wild-type and tau
knockout neurons expressing APPOSK (Fig. 4c, d). These
results indicate that iAβO-induced spine alteration is in-
dependent of tau.
iAβOs disrupt axonal and dendritic transport of BDNF
What is the cellular mechanism underlying the spine al-
terations caused by iAβOs? Notably, BDNF is known to
increase spine density and the proportion of mature
spines. Furthermore, reduced levels of BDNF correlate
with AD progression [17, 47]. We speculated that iAβOs
disrupt vesicular transport of BDNF to sites of release in
axons and dendrites, thereby inducing spine alteration.
To test this hypothesis, we analyzed axonal and den-
dritic transport of BDNF in living neurons. Wild-type
mouse primary neurons were transfected with APP-
EGFP and BDNF-mRFP. After video recording, neurons
Fig. 6 Axonal and dendritic transport of BDNF is impaired in APPOSK-expressing tau knockout neurons. Tau knockout mouse primary neurons were
doubly transfected with APP-EGFP and BDNF-mRFP. Transport of BDNF in living neurons was recorded for 25 s, and those in 100-μm segments of the
axon (a) and 45-μm segments of the dendrite (c) were analyzed. b Compared with mock-transfectants, APPWT-expressing cells showed no differences
in BDNF transport in axons. In contrast, APPOSK-expressing cells showed a significant decrease of anterograde, retrograde, and total axonal flux of BDNF.
d In dendrites, both APPWT- and APPOSK-expressing cells showed a decrease of BDNF transport, but the differences were significant only in
APPOSK-expressing cells
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Fig. 7 Impaired axonal transport and aberrant dendritic distribution of mitochondria in APPOSK-expressing neurons. Rat primary neurons
were triply transfected with APP, Mt-eYFP, and BFP. a Transport of mitochondria in living neurons was recorded for 300 s, and those in
100-μm segments of the axon were analyzed. b Compared with mock-transfectants, bidirectional transport of mitochondria in axons was
reduced in APPOSK-, but not APPWT-, expressing cells. c In dendrites, mitochondria were evenly distributed along the dendritic shafts in
mock-transfectants (a-c) and APPWT-expressing cells (d-f). In contrast, mitochondria in dendrites of APPOSK-expressing cells (g-i) were of
shorter length and unevenly distributed. Scale bar, 20 μm
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were fixed and stained with an antibody to MAP2, a
dendrite-specific microtubule-associated protein, to dis-
tinguish dendrites from axons. Compared with mock-
transfectants, both APPWT- and APPOSK-expressing cells
showed a decrease of anterograde, retrograde, and total
axonal flux of BDNF, but the differences were significant
only in APPOSK-expressing cells (Fig. 5a, b; flux is an
index of transport described in the Materials and
Methods). Similar results were obtained in dendrites: A
decrease in bidirectional transport of BDNF was ob-
served in both APPWT- and APPOSK-expressing neurons,
but significant reduction was observed only for total
transport in APPOSK-expressing neurons (Fig. 5c, d).
These results support our speculation that iAβOs cause
spine alterations via the blockade of BDNF transport
that is required to supply sites of release.
iAβOs disrupt axonal and dendritic transport of BDNF
independent of tau
We showed that iAβO-induced spine alteration is inde-
pendent of tau (Fig 4), but it is unknown if this tau-
independence extends to other cellular mechanisms such
as intracellular transport. To determine if iAβO-induced
BDNF transport defects are tau independent, we analyzed
transport of BDNF in tau knockout mouse neurons.
APPWT-expressing cells showed no differences in BDNF
transport in axons compared to mock-transfectants
(Fig. 6a, b). In contrast, APPOSK-expressing cells showed
a significant decrease of anterograde, retrograde, and total
axonal flux of BDNF, similar to wild-type neurons (Fig. 5).
In the dendrites of APPOSK-expressing neurons, BDNF
transport was also significantly reduced (Fig. 6c, d). Simi-
lar to the effects of eAβOs [48, 49], these results indicate
that iAβOs impair BDNF transport independent of tau.
Axonal transport and dendritic distribution of mitochondria
are disrupted by iAβOs
Mitochondria are essential for synaptic function as they
provide ATP for synaptic transmission and contribute to
local calcium buffering [13]. Because mitochondrial and
BDNF transport are both microtubule-dependent, it is
likely that mitochondrial transport is also affected by
iAβOs. To test this possibility, rat primary neurons were
triply transfected with APP, Mt-eYFP, and BFP. Live im-
aging analysis revealed that bidirectional transport of
mitochondria in axons was reduced in APPOSK-, but not
APPWT-, expressing cells compared with mock-
transfectants (Fig. 7a, b). In dendrites, mitochondria
were evenly distributed along the dendritic shafts in
mock-transfectants and APPWT-expressing cells (Fig. 7c).
In contrast, mitochondria in dendrites of APPOSK-ex-
pressing cells were of shorter length and unevenly dis-
tributed, implying aberrant transport or a change in
fission-fusion dynamics [50]. The latter finding may sup-
port our previous observation that mitochondrial net-
work was fragmented in COS-7 cells expressing APPOSK
[32]. These results indicate that the disruption of mito-
chondria transport may also contribute to the spine al-
terations observed in neurons accumulating iAβOs.
Dendritic transport of TfR-labeled endosomes is impaired
by iAβOs
Spine formation and growth requires membrane traffick-
ing mediated by recycling endosomes [51]. Thus, we
examined the effects of iAβOs on the dendritic transport
of recycling endosomes. Rat primary neurons were triply
transfected with APP, TfR-GFP, and BFP. TfR is a marker
protein localized to recycling endosomes. Live imaging
analysis revealed that bidirectional transport of TfR-
positive vesicles in dendrites was reduced in APPOSK-,
but not APPWT-, expressing cells compared with mock-
transfectants (Fig. 8). These results suggest that the im-
pairment of recycling endosome transport may also con-
tribute to the spine alteration caused by iAβOs.
Discussion
In the present study we showed that iAβOs, generated by
APPOSK expression in cultured neurons, impaired axonal
Fig. 8 Impaired dendritic transport of recycling endosomes in APPOSK-expressing neurons. Rat primary neurons were triply transfected with APP, TfR-
GFP, and BFP. a Transports of TfR in living neurons were recorded for 100 s, and those in 45-μm segments of the dendrite were analyzed. b Compared
with mock-transfectants, bidirectional transport of TfR-positive vesicles in dendrites was reduced in APPOSK-, but not APPWT-, expressing cells
Umeda et al. Acta Neuropathologica Communications  (2015) 3:51 Page 11 of 15
and dendritic transport of BDNF, mitochondria, and den-
dritic recycling endosomes (Figs. 5, 7 and 8). Because
these cargoes are critical for spine formation and mainten-
ance, reduced trafficking may have led to the observed
decreases in spine density and in the number of mature
mushroom spines (Fig. 2). Our results are significant be-
cause intraneuronal accumulation of Aβ precedes its
extracellular deposition in patients and AD model mice;
thus, iAβOs likely contribute to the early synaptic
pathology in AD. Moreover, multiple lines of evidence
demonstrate that trafficking defects are either an early cel-
lular pathology or even causal in AD [52], underscoring
the importance of defining iAβO mechanisms of action.
BDNF transport defects in APPOSK neurons may re-
duce the amount of BDNF available for secretion, and in
turn, compromise dendritic spine maturation and dens-
ity. Spines are the primary site of excitatory input on
neurons, and a reduced spine number and changes in
morphology contribute to synaptic pathology in AD.
BDNF secreted from cells binds to and activates TrkB
receptors that are located on both presynaptic axon
terminals and postsynaptic dendritic spines of gluta-
matergic synapses [53]. BDNF-induced TrkB signaling
modulates synaptic transmission by enhancing presynap-
tic glutamate release and increasing the open probability
of postsynaptic NMDA receptor ion channel [53]. In-
creased NMDA receptor currents activate the Rac1
(Ras-related C3 botulinum toxin substrate 1) pathway
and suppress cofilin, an actin-depolymerizing factor,
thereby promoting spine growth and stabilization [54].
Thus, iAβO-induced transport impairment may reduce
the amount of BDNF available for secretion, leading to
synaptic impairment and spine reduction.
We also found that iAβOs impair transport of mito-
chondria and recycling endosomes, which are essential for
spine development and maintenance. Mitochondria trans-
locate to pre- and postsynaptic regions to supply ATP for
neurotransmission [13]. A reduction in ATP availability
may reduce presynaptic secretion of essential signaling
molecules such as glutamate and BDNF, and thereby, as
similarly described above, impair postsynaptic signaling of
cascades such as Ca2+/calmodulin-dependent protein kin-
ase II (CaMKII) and Rac 1 that are required for spine
maintenance [54–56]. A role for dendritic mitochondria is
to buffer synaptic calcium; excess calcium may negatively
regulate actin-binding proteins that are required for main-
taining for spine density and plasticity (discussed below)
[12, 57]. Thus, perturbations in mitochondrial motility or
morphology induced by iAβOs likely diminish spine struc-
ture stemming from multiple mechanisms. Recycling
endosomes also play an essential role in spine morph-
ology. Elegant studies from the Ehlers laboratory demon-
strated that active transport of recycling endosomes
supplies necessary plasma membrane lipids and proteins
required to support spine structure and function [51].
Taken together, iAβO-induced intracellular transport dis-
ruption is likely an important contributor to mature spine
loss in APPOSK-expressing neurons.
iAβOs may disrupt intracellular transport by perturb-
ing motor function through second message cascades or
by directly binding to motor proteins. eAβO binding to
membrane targets results in changes in kinase and phos-
phatase activity leading to transport blockade of organ-
elles, including mitochondria and BDNF-containing
vesicles [9–11, 48, 58–60]. Similarly, organelle transport
is reduced in squid axoplasm perfused with AβOs via ac-
tivation of casein kinase 2 [61], providing evidence that
iAβOs impinge on signaling cascades that reduce traf-
ficking. It is likely that APPOSK dysregulates intracellular
Ca2+ signaling via ER stress and mitochondrial damage
[32] that may ultimately have negative consequences on
the mechanisms that regulate transport. For example,
mitochondria transport is governed by Miro-Milton-
Kinesin-I in a Ca2+-dependent mechanism, where Ca2+
binding to Miro inhibits Kinesin-I-based motility [62]. It
is thus possible that the APPOSK effects on intracellular
Ca2+ result in a blockade of mitochondria transport.
Moreover, Ca2+ signaling may represent a general mech-
anism for the regulation of microtubule-based transport.
The transport of dense core vesicles containing neuro-
peptides [63] and the dendritic kinesin, KIF17, ferrying
the NR2B glutamate receptor subunit [64], are also sub-
ject to Ca2+ regulation, demonstrating that perturbations
in Ca2+ homeostasis likely have broader effects on or-
ganelle trafficking. A second possible mechanism of
transport disruption is the direct binding of iAβOs or
Aβ to motor proteins [65]. Ari et al. demonstrate mislo-
calization of NMDA receptors and NGF/NTR (p75) at
the post-synaptic membrane due to intracellular Aβ
binding the mitotic kinesin Eg 5 [66].
Despite a plethora of recent reports, the role of tau in
transport disruption is still a matter of debate. In vivo
studies demonstrate that axonal transport is unaffected
by tau overexpression or suppression, or by moderate
amounts of hyperphosphorylated tau [67, 68]. In primary
culture, we have demonstrated that eAβO-induced
BDNF-transport disruption is independent of tau [48, 49].
However, other studies suggest that phospho-tau inhibits
fast axonal transport (FAT) by interacting directly with
motor-cargo complexes or initiating aberrant signaling
cascades that alter FAT dynamics [69, 70], and that tau re-
duction prevents AβO-induced defects in mitochondria
and neurotrophin receptor TrkA transport [10, 60]. It is
possible that transport defects are motor and/or cargo
dependent. For example, mitochondria are transported
primarily by KIF5 whereas BDNF is transported primarily
by KIF1A [71]. Kinesins may be differentially affected by
hyperphosphorylated tau, thus, we cannot rule out that in
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our studies the reduction in mitochondria and endosome
transport is tau-dependent. How APPOSK and tau influ-
ences organelle transport is a focus of ongoing studies.
Similar to the initiation of transport deficits, iAβO-
induced signaling cascades may compromise dendritic
spine maturation and density. Actin, a critical structural
component of spines, is tightly regulated by actin-
binding proteins and their associated kinases and phos-
phatases [72]. eAβOs reduce spine density and alter
morphology by at least two mechanisms: one is the mis-
localization of p21-activated kinase (PAK), and another
is the activation of the calcineurin, a calcium-dependent
phosphatase implicated in AD. Changes in these signal-
ing cascades alter the dynamics of actin-binding proteins
needed to maintain and stabilize spine actin [73–75].
Through a yet unexplored mechanism, iAβOs may also
impinge on the regulation of actin-binding proteins that
lead to spine retraction. Consistent with our previous
findings for eAβOs, we show that iAβO-induced BDNF
transport defects and spine loss occur independent of
tau. These effects are likely caused by signaling cascade
activation, such as the calcineurin-GSK3β pathway, that
persists in the absence of tau [48]. Because tau knockout
mice do not exhibit any serious health or cognitive defi-
cits, some researchers proposed that lowering endogen-
ous tau is a beneficial treatment to protect neurons from
Aβ toxicity [76]. However, our results imply that such
tau-reducing therapy would result in failure to prevent
Aβ-induced spine alteration.
Although AβOs generated by the Osaka mutation are
mostly intracellular, picomolar amounts are released
from cells (ELISA data; this study). We found that extra-
cellular wild-type Aβ showed a trophic effect on synap-
ses at physiological low concentrations; however, Osaka-
mutant Aβ showed no trophic effect on spines. Recent
evidence suggests that endogenous Aβ modulates synap-
tic plasticity [40, 41] and regulates neurotransmitter re-
lease probability [77]. These positive effects of Aβ are
observed at picomolar concentrations, and higher, nano-
molar concentrations lead to toxicity. In cultured hippo-
campal slices, we previously observed that relatively low
concentrations of wild-type Aβ enhanced the levels of
synaptophysin, whereas Osaka-mutant Aβ did not [42].
In the present study, unlike wild-type Aβ, Osaka-mutant
Aβ did not show trophic effects on spines at the same
low concentrations. The lack of such trophic actions
may in part account for the synaptic alteration associ-
ated with APPOSK.
Conclusion
In summary, we showed that iAβOs reduce mature
dendritic spines and block axonal and dendritic trans-
port in primary neurons. Both the spine alteration
and BDNF transport blockade are tau-independent.
iAβO-induced spine alterations may be caused by de-
regulating enzymes within dendritic spines and/or by
reducing axonal and dendritic transport of organelles
and proteins necessary for spine formation and main-
tenance. Furthermore, extracellular Osaka-mutant Aβ
lacks the trophic effect on spines, likely inflicting a
dual assault on spines in AD. This work is significant
because iAβO generation precedes extracellular Aβ
accumulation and these data will promote further in-
vestigation of iAβO toxicity with the hope to develop
therapeutic compounds for prevention and treatment
of AD.
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